Yüklüyor......
Obeticholic acid ameliorates obesity and hepatic steatosis by activating brown fat
Obeticholic acid (OCA) is exemplified as a potent drug for treating primary biliary cirrhosis and nonalcoholic fatty liver disease by inhibiting bile acid synthesis. However, it remains unclear whether the effect of OCA is mediated by the function of brown adipose tissue (BAT). In the present study,...
Kaydedildi:
| Yayımlandı: | Exp Ther Med |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
D.A. Spandidos
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8311225/ https://ncbi.nlm.nih.gov/pubmed/34345273 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2021.10423 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|